Upgrade to SI Premium - Free Trial

Heron Therapeutics (HRTX)

0.46 -0.01 (2.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 4 HERON THERAPEUTICS, INC. For: Jul 19 Filed by: Collard Craig A July 20, 2026 4:23 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Jul 19 Filed by: Forbes William P July 20, 2026 4:10 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Jul 19 Filed by: Duarte Ira July 20, 2026 3:54 PM - SEC Filing Form 8-K HERON THERAPEUTICS, INC. For: Jun 25 June 25, 2026 5:00 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Jun 16 Filed by: Duarte Ira June 17, 2026 10:52 AM - SEC Filing Form 8-K HERON THERAPEUTICS, INC. For: Jun 11 June 16, 2026 2:49 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Jun 06 Filed by: Forbes William P June 8, 2026 10:29 AM - SEC Filing Heron Therapeutics (HRTX) PT Lowered to $2 at H.C. Wainwright June 3, 2026 6:22 AM - StreetInsider Form 8-K HERON THERAPEUTICS, INC. For: Jun 02 June 2, 2026 5:15 PM - SEC Filing Needham Downgrades Heron Therapeutics (HRTX) to Hold June 2, 2026 4:00 PM - StreetInsider Heron Therapeutics loses patent case for CINVANTI drug June 2, 2026 8:12 AM - StreetInsider U.S. District Court Issues Decision Regarding CINVANTI® Patents June 2, 2026 8:12 AM - Globe NewsWire Form SCHEDULE 13G/A HERON THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P. May 13, 2026 9:06 AM - SEC Filing Heron Therapeutics (HRTX) PT Lowered to $4 at H.C. Wainwright May 12, 2026 6:51 AM - StreetInsider Heron Therapeutics (HRTX) Misses Q1 EPS by 2c ; Offers Guidance May 11, 2026 8:06 AM - StreetInsider Form 10-Q HERON THERAPEUTICS, INC. For: Mar 31 May 11, 2026 8:01 AM - SEC Filing Form 8-K HERON THERAPEUTICS, INC. For: May 11 May 11, 2026 8:00 AM - SEC Filing Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance May 11, 2026 8:00 AM - Globe NewsWire Form 4 HERON THERAPEUTICS, INC. For: May 06 Filed by: Hensley Mark Earl May 7, 2026 1:01 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Apr 30 Filed by: Hensley Mark Earl May 4, 2026 12:49 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Apr 30 Filed by: Forbes William P May 4, 2026 12:36 PM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Apr 30 Filed by: Duarte Ira May 4, 2026 11:56 AM - SEC Filing Form 4 HERON THERAPEUTICS, INC. For: Apr 30 Filed by: Collard Craig A May 4, 2026 11:31 AM - SEC Filing Form ARS HERON THERAPEUTICS, INC. For: Dec 31 April 30, 2026 2:11 PM - SEC Filing Form DEFA14A HERON THERAPEUTICS, INC. April 30, 2026 2:10 PM - SEC Filing Form DEF 14A HERON THERAPEUTICS, INC. For: Apr 30 April 30, 2026 2:09 PM - SEC Filing Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 April 27, 2026 5:30 PM - StreetInsider Full Article List